Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds SAQsendocrinology-diabetes-and-growth

Paeds SAQs · endocrinology-diabetes-and-growth

Tall stature and overgrowth syndromes — formative SAQs

Formative SAQs on tall stature and overgrowth syndromes: separating the familial normal variant from the pathological causes using a structured redistribution assessment, recognising the syndromic overgrowth fingerprint (Sotos, Beckwith-Wiedemann, Weaver), the tumour surveillance that the molecular subgroup dictates, and the treatable endocrine and chromosomal causes.

20 marks30 min2 min readVerification in progress

Target exams

RACP General PaediatricsMRCPCH ClinicalRACP DWE
On this page
Study tools

Target exams

RACP General PaediatricsMRCPCH ClinicalRACP DWE
Prompt
Tall stature and overgrowth syndromes in paediatric practice

SAQ 1 (10)

A large-for-gestational-age term infant is reviewed at six weeks of age. The mother notes the baby's tongue seems large and protrudes, and the umbilicus has not healed well. On examination the baby is on the 99.6th centile for weight and length, has a markedly enlarged tongue, a soft umbilical hernia, and the left leg is measurably longer and thicker than the right. [2] [9]

a) What is the most likely diagnosis, and which molecular test confirms it and defines the tumour-risk subgroup? Give the reasoning. (3 marks) [2]

b) Outline the tumour surveillance plan this child must now enter, including the imaging modality, the frequency, the age horizon, and the tumours targeted. (3 marks) [9]

c) Describe the neonatal complications that may have required management in the first days of life, naming at least three. (2 marks) [2]

d) The parents ask whether their next child will be affected. Outline the principles of the recurrence-risk counselling for this condition. (2 marks) [2]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References5ShowHide
  1. [1]Ocansey S, Cole TRP, Rahman N, et al. Sotos Syndrome. GeneReviews, 1993.PMID 20301652
  2. [2]Brioude F, Kalish JM, Mussa A, et al. Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome. Nat Rev Endocrinol, 2018.PMID 29377879
  3. [6]Caro R, Savel P, Moss PI. Evaluation of Short and Tall Stature in Children. Am Fam Physician, 2025.PMID 40531152
  4. [8]Tatton-Brown K, Loveday C, Yost S, et al. Mutations in Epigenetic Regulation Genes Are a Major Cause of Overgrowth with Intellectual Disability. Am J Hum Genet, 2017.PMID 28475857
  5. [9]Maas SM, Vansenne F, Kadouch DJ, et al. Phenotype, cancer risk, and surveillance in Beckwith-Wiedemann syndrome depending on molecular genetic subgroups. Am J Med Genet A, 2016.PMID 27419809
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousSIADH and disorders of water balance — formative SAQsendocrinology-diabetes-and-growthNextThyroid nodules, goitre and thyroid cancer — formative SAQsendocrinology-diabetes-and-growth